Lh. Caldera et al., BONE-MARROW AND PERIPHERAL-BLOOD NATURAL-KILLER-CELL ACTIVITY IN LYMPHOMAS - ITS RESPONSE TO IL-2, Clinical and experimental immunology, 88(1), 1992, pp. 143-148
Natural killer (NK) cytotoxic activity was simultaneously investigated
in bone marrow mononuclear cells (BMMC) and peripheral blood lymphocy
tes (PBL) from nine Hodgkin's disease (HD) and 15 non-Hodgkin lymphoma
(NHL) untreated patients. Twenty-five PBL samples and seven bone marr
ow specimens from healthy individuals were also included as control gr
oup (C). NK cell activity was evaluated in basal condition and post-st
imulation with human recombinant IL-2 (rIL-2). Data were expressed in
K values (number of BMMC or PBL needed to lyse 50% of the target cells
). In basal condition, both HD and NHL patients showed a NK cell activ
ity comparable to the C group, both in BMMC (HD, K = 2.48 +/- 1.3; NHL
, K = 3.8 +/- 2.0; C, K = 3.2 +/- 0.7) and PBL (HD, K = 2.0 +/- 1.0; N
HL, K = 2.3 +/- 1.0; C, K = 2.2 +/- 0.2). Stimulation with rIL-2 induc
ed a significant and comparable enhancement of the NK activity in PBL
from HD, NHL and C while the response to rIL-2 of the BMMC in most of
the HD and NHL patients was significantly greater than the C group. Re
sponder cells were characterized by negative selection with specific M
oAb plus complement as a CD3-, CD16+, CD56+ cytotoxic cell and further
confirmed by flow cytometry. We postulate that IL-2 activation of bon
e marrow NK cell precursors, in addition to enhancing the activity of
circulating NK, may be of value for the therapeutic rationale of IL-2
in patients with lymphoma.